Going Green With Tata Harper Elixir Vitae: The Future of Topical Treatment Skincare
The biggest buzz in skincare right now is topical injectibles, aka topical Botox. Allergan (who owns Botox) is spending $90 million up front, and promising undisclosed future cash for Anterios, a New York City biotech at work on technology that could allow neurotoxins to be delivered through the skin without the